Evidence map›Paper›PMID 35029636›Full record

ArticleInvestigative ophthalmology & visual science2022

The Phenotypic and Mutational Spectrum of the FHONDA Syndrome and Oculocutaneous Albinism: Similarities and Differences.

Charlotte C Kruijt, Libe Gradstein, Arthur A Bergen, Ralph J Florijn, Benoit Arveiler, Eulalie Lasseaux, Xavier Zanlonghi, Laura Bagdonaite-Bejarano, Anne B Fulton, Claudia Yahalom and 6 more

Open access · goldAbstract readComparative StudyMulticenter Study
In one paragraph

Article in Investigative ophthalmology & visual science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 4 countries.

Charlotte C KruijtBartiméus Diagnostic Center for Complex Visual Disorders, Zeist, The Netherlands.
Libe GradsteinDepartment of Ophthalmology, Soroka Medical Center and Clalit Health Services, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.
Arthur A BergenDepartment of Human Genetics, Amsterdam University Medical Center, Location AMC, Amsterdam, The Netherlands.
Ralph J FlorijnDepartment of Human Genetics, Amsterdam University Medical Center, Location AMC, Amsterdam, The Netherlands.
Benoit ArveilerMaladies Rares: Génétique et Métabolisme (MRGM), Inserm U1211, University of Bordeaux, Bordeaux, France.
Eulalie LasseauxDepartment of Medical Genetics, CHU Bordeaux, Bordeaux, France.
Xavier ZanlonghiCentre de Compétence Maladie Rares, Clinique Pluridisciplinaire Jules Verne, Nantes, France.
Laura Bagdonaite-BejaranoDepartment of Ophthalmology, Boston Children's Hospital, Boston, Massachusetts, United States.
Anne B FultonDepartment of Ophthalmology, Boston Children's Hospital, Boston, Massachusetts, United States.
Claudia YahalomFaculty of Medicine, Hebrew University of Jerusalem, Israel; Department of Ophthalmology, Hadassah Medical Center, Jerusalem, Israel.
Anat BlumenfeldFaculty of Medicine, Hebrew University of Jerusalem, Israel; Department of Ophthalmology, Hadassah Medical Center, Jerusalem, Israel.
Yonatan PerezThe Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev and Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.
Ohad S BirkThe Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev and Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.
Gerard C de WitBartiméus Diagnostic Center for Complex Visual Disorders, Zeist, The Netherlands.
Nicoline E Schalij-DelfosDepartment of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands.
Maria M van GenderenBartiméus Diagnostic Center for Complex Visual Disorders, Zeist, The Netherlands.
Ben-Gurion University of the Negev · ILBoston Children's Hospital · USHebrew University of Jerusalem · ILLeiden University Medical Center · NLAmsterdam University Medical Centers · NLBartiméus · NLClinique Jules Verne · FRNetherlands Institute for Neuroscience · NLUniversité de Bordeaux · FRUniversity Medical Center Utrecht · NL

Funding

Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI Hisashi Umemori · 2021 to 2026
$9.4M
NICHD NIH HHS P50 HD105351
6 · The paper itself

Abstract

Purpose: The purpose of this study was to further expand the mutational spectrum of the Foveal Hypoplasia, Optic Nerve Decussation defect, and Anterior segment abnormalities (FHONDA syndrome), to describe the phenotypic spectrum, and to compare it to albinism. Subjects and Methods: We retrospectively collected molecular, ophthalmic, and electrophysiological data of 28 patients molecularly confirmed with FHONDA from the Netherlands (9), Israel (13), France (2), and the United States of America (4). We compared the data to that of 133 Dutch patients with the 3 most common types of albinism in the Netherlands: oculocutaneous albinism type 1 (49), type 2 (41), and ocular albinism (43). Results: Patients with FHONDA had a total of 15 different mutations in SLC38A8, of which 6 were novel. Excluding missing data, all patients had moderate to severe visual impairment (median visual acuity [VA] = 0.7 logMAR, interquartile range [IQR] = 0.6-0.8), nystagmus (28/28), and grade 4 foveal hypoplasia (17/17). Misrouting was present in all nine tested patients. None of the patients had any signs of hypopigmentation of skin and hair. VA in albinism was better (median = 0.5 logMAR, IQR = 0.3-0.7, P 0.006) and the phenotypes were more variable: 14 of 132 without nystagmus, foveal hypoplasia grades 1 to 4, and misrouting absent in 16 of 74. Conclusions: Compared to albinism, the FHONDA syndrome appears to have a more narrow phenotypic spectrum, consisting of nonprogressive moderately to severely reduced VA, nystagmus, severe foveal hypoplasia, and misrouting. The co-occurrence of nystagmus, foveal hypoplasia, and misrouting in the absence of hypopigmentation implies that these abnormalities are not caused by lack of melanin, which has important implications for understanding the pathogenesis of these features.

Indexed as

MutationVisual AcuityAdolescentAdultAgedAlbinism, OculocutaneousAmino Acid Transport Systems, NeutralAnterior Eye SegmentChildChild, PreschoolDNADNA Mutational AnalysisFemaleFollow-Up StudiesFovea CentralisHumansAmino Acid Transport Systems, NeutralDNASlc38a8 protein, human

Identifiers

PMID35029636
PMCPMC8762694
OpenAlexW4205882044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.